Subscribe to RSS
DOI: 10.1055/s-2004-826028
Welchen Stellenwert hat die pumpenlose interventionelle Lungenassistenz (ILA) in der Intensivmedizin?
The Present Role of Interventional Lung Assist (ILA) in Critical Care MedicinePublication History
Publication Date:
16 February 2005 (online)
![](https://www.thieme-connect.de/media/ains/200502/lookinside/thumbnails/10.1055-s-2004-826028-1.jpg)
Zusammenfassung
Die Entwicklung von Membranlungen mit niedrigem Flusswiderstand kann das therapeutische Spektrum in der Behandlung des Akuten Lungenversagens (ARDS) erweitern. Für eine Subgruppe von Patienten mit ARDS eröffnet die Einführung der interventionellen Lungenassistenz (ILA) mit Hilfe pumpenloser, durch die arterio-venöse Druckdifferenz betriebener Systeme eine zusätzliche therapeutische Option. Die ILA hat das Potenzial, im Rahmen eines multimodalen Konzeptes frühzeitig in der ARDS-Therapie eingesetzt werden zu können.
Abstract
The development of low resistance oxygenators widens the therapeutic options for patients with acute respiratory failure (ARDS). Pumpless arteriovenous interventional lung assist systems (ILA) can be used in a subgroup of patients with ARDS. ILA might be indicated in earlier stages of ARDS following a multimodal treatment approach.
Schlüsselwörter
ECMO · ILA · ECLA · ARDS · Intensivmedizin
Key words
ECMO · ILA · ECLA · ARDS · intensive care
Literatur
- 1 Ashbaugh D G, Bigelow D B, Petty T L, Levine B E. Acute respiratory distress in adults. Lancet. 1967; 2 319-323
- 2 Zapol W M, Snider M T, Hill J D, Fallat R J, Bartlett R H, Edmunds L H, Morris A H, Peirce E C 2nd, Thomas A N, Proctor H J, Drinker P A, Pratt P C, Bagniewski A, Miller R G Jr. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA. 1979; 242 2193-2196
- 3 Morris A H, Wallace C J, Menlove R L, Clemmer T P, Orme J F Jr, Weaver L K, Dean N C, Thomas F, East T D, Pace N L. Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med. 1994; 149 295-305
- 4 Gattinoni L, Pesenti A, Mascheroni D, Marcolin R, Fumagalli R, Rossi F, Iapichino G, Romagnoli G, Uziel L, Agostoni A. Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. JAMA. 1986; 256 881-886
- 5 Amato M, Barbas C, Medeiros D, Magaldi R, Schettino G, Lorenzi-Filho G, Kairalla R, Deheinzelin D, Munoz C, Oliveira R, Takagaki T, Carvalho C. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med. 1998; 338 347-354
- 6 Philipp A, Reng C, Behr R, Kaiser M, Birnbaum D. Extrakorporale Lungenunterstützung ohne Pumpe. Pumpless ECLA - ein Fallbeispiel. Kardiotechnik. 1997; I 3-7
- 7 Brunston R, Tao W, Bidani A, Alpard S, Traber D, Zwischenberger J. Prolonged hemodynamic stability during arteriovenous carbon dioxide removal for severe respiratory failure. J Thorac Cardiovasc Surg. 1997; 114 1107-1114
- 8 Zwischenberger J, Conrad S, Alpard S, Grier L, Bidani A. Percutaneous extracorporeal arteriovenous CO2 removal for severe respiratory failure. Ann Thorac Surg. 1999; 68 181-187
- 9 Tao W, Brunston R, Bidani A, Pirtle P, Dy J, Cardenas V, Traber D, Zwischenberger J. Significant reduction in minute ventilation and peak inspiratory pressures with arteriovenous CO2 removal during severe respiratory failure. Crit Care Med. 1997; 25 689-695
- 10 Reng M, Philipp A, Kaiser M, Pfeifer M, Gruene S, Schoelmerich J. Pumpless extracorporeal lung assist and adult respiratory distress syndrome. Lancet. 2000; 356 219-220
- 11 Brederlau J, Anetseder M, Wagner R, Roesner T, Philipp A, Greim C, Roewer N. Pumpless extracorporal lung assist in severe blunt chest trauma. J Cardiothorac Vasc Anesth; in press.
- 12 Bein T, Kuhr L, Metz C, Woertgen C, Philipp A, Taeger K. ARDS and severe brain injury. Therapeutic strategies in conflict. Anaesthesist. 2002; 51 552-556
- 13 Murphy J, Savage C M, Alpard S, Deyo D, Jayroe J, Zwischenberger J. Low-dose versus high-dose heparinization during arteriovenous carbon dioxide removal. Perfusion. 2001; 16 460-468
- 14 Jayroe J, Alpard S, Wang D, Deyo D, Murphy J, Zwischenberger J. Hemodynamic stability during arteriovenous carbon dioxide removal for adult respiratory distress syndrome: a prospective randomized outcomes study in adult sheep. ASAIO J. 2001; 47 211-214
- 15 Brunston R, Tao W, Bidani A, Alpard S, Traber D, Zwischenberger J. Prolonged hemodynamic stability during arteriovenous carbon dioxide removal for severe respiratory failure. J Thorac Cardiovasc Surg. 1997; 114 1107-1114
- 16 Jayroe J B, Wang D, Deyo D J, Alpard S K, Bidani A, Zwischenberger J. The effect of augmented hemodynamics on blood flow during arteriovenous carbon dioxide removal. ASAIO J.. 2003; 49 30-34
- 17 McCulloch P, Forkert P, Froese A. Lung volume maintenance prevents lung injury during high frequency oscillatory ventilation in surfactant-deficient rabbits. Am Rev Respir Dis. 1988; 137 1185-1192
- 18 Derdak S, Mehta S, Stewart T, Smith T, Rogers M, Buchman T, Carlin B, Lowson S, Granton J. Multicenter Oscillatory Ventilation For Acute Respiratory Distress Syndrome Trial (MOAT) Study Investigators. High-frequency oscillatory ventilation for acute respiratory distress syndrome in adults: a randomized, controlled trial. Am J Respir Crit Care Med. 2002; 166 786-787
- 19 Müller T, Budweiser S, Muders F, Schulz C, Jeron A, Neuhierl F, Riegger G, Pfeifer M. Hochfrequenzoszillation beim akuten Lungenversagen des Erwachsenen. Dtsch Arztebl. 2004; 101 A 928-934
Dr. J. Brederlau
Klinik und Poliklinik für Anästhesiologie, Zentrum Operative Medizin, Universitätsklinikum Würzburg
Oberdürrbacher Straße 6 · 97080 Würzburg
Email: brederlau_j@klinik.uni-wuerzburg.de